We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VALE3:BMFBOVESPAVale S.A. Analysis

Data as of 2026-06-04 - not real-time

ARS 24,630.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Vale’s share price is trading above its short‑term moving average, reinforcing a bullish technical bias. The MACD indicator is in bullish territory, while the RSI hovers around the neutral zone, suggesting limited over‑extension. A strong positive MACD histogram adds momentum to the upside. Trading volume has been on a downward trend, which could temper short‑term enthusiasm. Recent price action sits close to a key resistance level, hinting at a potential ceiling. The stock exhibits a beta above one and elevated recent volatility, pointing to heightened systematic risk.
Fundamentally, revenue growth remains modest and profit margins are only moderate. The balance sheet is weighted heavily toward debt, resulting in a very high debt‑to‑equity ratio. Cash generation is positive but free cash flow is limited relative to the scale of operations. The company does not pay a dividend, eliminating yield‑focused income appeal. A discounted cash flow model places intrinsic value well below the current market price, flagging the stock as overvalued. Operating in the basic materials sector introduces commodity price sensitivity, regulatory scrutiny, and exposure to Brazil‑centric geopolitical and currency dynamics.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • price above moving averages but near resistance
  • decreasing volume and high volatility
  • overvalued relative to intrinsic estimate

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • moderate revenue growth and margins
  • high debt burden limiting flexibility
  • commodity price exposure

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • structural demand for iron ore and base metals
  • ongoing ESG and regulatory pressures
  • persistent balance‑sheet leverage

Key Metrics & Analysis

Financial Health

Revenue Growth2.70%
Profit Margin7.26%
ROE6.84%
ROA8.19%
Debt/Equity57.15
P/B Ratio2.1
Op. Cash FlowARS48.8B
Free Cash FlowARS10.6B

Technical Analysis

TrendBullish
RSI50.7
SupportARS 23,180.00
ResistanceARS 25,700.00
MA 20ARS 24,526.50
MA 50ARS 24,447.60
MA 200ARS 20,508.85
MACDBullish
VolumeDecreasing
Fear & Greed Index92.75

Valuation

Fair ValueARS 17.13
GradeOvervalued
TypeValue

Risk Assessment

Beta1.15
Volatility42.73%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.